对阴囊变性及其并发症模式的遗传责任:英国生物银行的一项全现象关联研究
Dong-Gi Lee1, Yonghyun Nam1, Jaehyun Joo1
1Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
medRxiv : the preprint server for health sciences
|October 3, 2025
概括
阴茎退化的遗传遗传风险与膝盖以外的更广泛的健康问题有关. 这种遗传重叠表明与代谢和心血管疾病有共同的途径,影响整体健康.
科学领域:
- 遗传学 遗传学 是一个
- 整形外科 整形外科 整形外科
- 系统生物学 系统生物学
背景情况:
- 阴茎退化是一种普遍的膝盖疾病,导致疼痛,残疾和骨关节炎.
- 遗传遗传因素在半月膜退化的系统性模式中的作用尚未得到充分理解.
研究的目的:
- 为了研究多基因风险评分 (PRS) 对阴囊变性病变的全现象关联.
- 探索阴茎退化和其他临床表型之间的共同遗传结构.
主要方法:
- 在323,999名英国生物库参与者身上应用了从FinnGen GWAS数据中获得的阴囊变性PRS.
- 在962种临床表型中进行了一项全现象关联研究 (PheWAS).
- 使用链接不平衡得分回归和基因型-组织表达 (GTEx) 分析.
主要成果:
- 阴囊退化的PRS与肌肉骨,代谢,心血管,精神和胃肠道领域的表型有显著的关联.
- 强烈的遗传相关性被证实与骨关节炎和相关的关节病.
- GTEx分析确定了关键基因 (例如GDF5,SOX5,BMP6) 在结合性和代谢组织中的组织特异性表达.
结论:
- 阴茎退化的遗传责任延伸到膝盖之外,涉及与各种系统性疾病共享的遗传通路.
- 这些发现突出了广泛的遗传结构,将膝盖健康与全身性疾病联系起来.
- 需要采用综合管理方法,将骨科护理与代谢和生活方式干预相结合.
相关概念视频
Pedigree Analysis
Overview
Incomplete Dominance
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...


